COSM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Cosmos Health Inc (COSM) does not currently present a strong buy opportunity for a beginner investor with a long-term strategy. The stock shows weak technical indicators, limited positive catalysts, and poor financial performance, making it unsuitable for immediate investment.
The MACD is slightly positive but expanding, indicating weak bullish momentum. RSI is neutral at 48.308, showing no clear trend. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the price is below the pivot level of 0.384, with key resistance at 0.414 and support at 0.354. Overall, the technical indicators suggest a bearish trend.
The appointment of Dr. Dimitrios Iliopoulos to the Advisory Board may enhance the company's biotechnology platform and drive growth in therapeutic areas.
The stock is experiencing consistent price declines across pre-market, regular market, and post-market sessions. Additionally, hedge funds and insiders show neutral trading activity, and there are no significant trading trends or recent congress trading data.
In Q3 2025, revenue increased by 37.86% YoY to $17,110,425, but net income dropped by 36.10% YoY to -$5,352,890. EPS declined significantly by 62.22% YoY to -0.17, indicating poor profitability. Gross margin improved by 78.82% YoY to 13%, but overall financial performance remains weak.
No data available for analyst ratings or price target trends.
